Autoradiography of receptor-activated G-proteins in post mortem human brain

Neuroscience

Volumn 96, Issue 1, 2000, Pages 169-180

  Rodriguez Puertas R ^a   Gonzalez Maeso J ^a   Meana, J J ^a   Pazos, A ^b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

2 adrenoceptors; opioid receptors; 5 HT1 receptors; 35S GTP S binding; Cannabinoid receptors; Cholinergic muscarinic receptors

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ALPHA 2 ADRENERGIC RECEPTOR; BRIMONIDINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CARBACHOL; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; SEROTONIN 1 RECEPTOR; SUMATRIPTAN;

ARTICLE; AUTOPSY; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN STEM; CONTROLLED STUDY; DRUG EFFICACY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

ADULT; AUTORADIOGRAPHY; BRAIN; CADAVER; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; RECEPTORS, CELL SURFACE; TISSUE DISTRIBUTION;

EID: 0342679997     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00527-8     Document Type: Article

References (66)

1. Birnbaumer L., Abramowitz J., Brown A.M. Receptor-effector coupling by G proteins. Biochim. biophys. Acta. 1031:1990;163-224.
2. Brodde O.-E., Michel M.C. Disease states can modify both receptor number and signal transduction pathways. Trends pharmac. Sci. 8:1989;383-384.
3. Cassel D., Selinger Z. Cathecolamine-stimulated GTPase activity in turkey erythrocyte membranes. Biochim. biophys. Acta. 452:1976;538-551.
4. 1F) in human brain: focus on brainstem and spinal cord. Neuropharmacology. 36:1997;535-542.
5. 2-adrenergic receptor with guanine nucleotide regulatory proteins in phospholipid vesicles. J. biol. Chem. 261:1986;3901-3909.
6. Clapham D.E., Neer E.J. G protein βγ subunits. A. Rev. Pharmac. Toxic. 37:1997;167-203.
7. 35S]GTPγS binding shows regional selective changes in Alzheimer's disease postmortem brain. Neurodegeneration. 5:1996;19-26.
8. DeArmond S. J., Fusco M. M. and Dewey M. M. (1989) Structure of the Human Brain. A Photographic Atlas, 3rd edn. Oxford University Press, New York.
9. De Vivo M., Maayani S. Characterization of the 5-hydroxytriptamine1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes. J. Pharmac. exp. Ther. 238:1996;248-253.
10. 35S]GTPγS binding. J. Neurochem. 70:1998;1258-1268.
11. Friedman E., Wang H.-Y. Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects. J. Neurochem. 67:1996;1145-1152.
12. 3H]forskolin binding in the rat brain by guanylyl-5′-imidodiphosphate and sodium fluoride: comparison with the distribution of guanine nucleotide binding sites. J. Pharmac. exp. Ther. 239:1986;952-958.
13. + regulation of formyl peptide receptor-mediated signal transduction in HL 60 cells. Evidence that the cation prevents activation of the G-protein by unoccupied receptors. Eur. J. Pharmac. 172:1989;481-492.
14. Gilman A. G proteins: transducers of receptor-generated signals. A. Rev. Biochem. 56:1987;615-649.
15. Glass M., Dragunow M., Faull L.M. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 77:1997;299-318.
16. 35S]GTPγS binding to cortical membranes from postmortem human brain. Eur. J. Pharmacol. (in press).
17. 3H]RX-821002 binding to membranes and tissue sections. Eur. J. Pharmac. 310:1996;83-93.
18. 11C]WAY-100635. Brain Res. 745:1997;96-108.
19. Herkenham M., Lynn A.B., Little M.D., Johnson M.R., Melvin L.S., de-Costa B.R., Rice K.C. Cannabinoid receptor localization in brain. Proc. natn. Acad. Sci. U.S.A. 87:1990;1932-1936.
20. Hilf G., Gierschik P., Jakobs K.H. Muscarinic acetylcholine receptor-stimulated binding of guanosine 5′-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes. Eur. J. Biochem. 186:1989;725-731.
21. 1B recognition sites. Brain Res. 376:1986;85-96.
22. Hurd Y.L., Herkenham M. The human neostriatum shows compartmentalization of neuropeptide gene expression in dorsal and ventral regions: an in situ hybridization histochemical analysis. Neuroscience. 64:1995;571-586.
23. Koski G., Klee W.A. Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc. natn. Acad. Sci. U.S.A. 78:1981;4185-4189.
24. 35S]-GTPγS binding mediated by human muscarinic m1-m4 receptors: antagonist studies. Br. J. Pharmac. 109:1993;1120-1127.
25. Lorenz W., Lomasney J.W., Collins S., Regan J.W., Caron M.G., Lefkowitz R.J. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification. Molec. Pharmac. 38:1990;599-603.
26. 35S]thio)triphosphate binding. Molec. Pharmac. 44:1993;115-123.
27. Mailleux P., Vanderhaeghen J.-J. Localization of cannabinoid receptor in the human developing and adult basal ganglia. Higher levels in the striatonigral neurons. Neurosci. Lett. 148:1992;173-176.
28. Mailleux P., Verslijpe M., Vanderhaeghen J.-J. Initial observations on the distribution of cannabinoid receptor binding sites in the human adult basal ganglia using autoradiography. Neurosci. Lett. 139:1992;7-9.
29. Manji H.K. G proteins: implications for psychiatry. Am. J. Psychiat. 149:1992;746-760.
30. Marazziti D., Marraci S., Palego L., Rotondo A., Mazzanti C., Ladinsky H., Giraldo E., Borsini F., Cassano G.B. Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem. Brain Res. 658:1994;55-59.
31. 3H]UK14304. J. Neurochem. 52:1989;1210-1217.
32. Mengod G., Palacios J.M., Probst A., Harris B. Regional distribution of the expression of a human stimulatory GTP-binding protein α-subunit in the human brain studied by in situ hybridization. Molec. Brain Res. 4:1988;23-29.
33. Mengod G., Vilaró M.T., Raurich A., López-Giménez F., Cortés R., Palacios J.M. 5-HT receptors in mammalian brain: receptor autoradiography and in situ hybridization studies of new ligands and newly identified receptors. Histochem. J. 28:1996;747-758.
34. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell. 80:1995;249-257.
35. 1A receptors. Eur. J. Pharmac. 307:1996;107-111.
36. Nieuwenhuys R., Voogd J. and van Huijzen C. (1988) The Human Nervous System. A Synopsis and Atlas. Springer, Berlin.
37. 35S]thiotriphosphate) binding by cholinergic muscarinic receptors in membranes of rat olfatory bulb. J. Neurochem. 67:1996;2549-2556.
38. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signalling and G-protein levels in depressed suicide brain. Brain Res. 723:1996;37-45.
39. 2-adrenoceptors in the human brain. Brain Res. 585:1992;116-127.
40. 1F receptors. Eur. J. Pharmac. 295:1996;271-274.
41. 1B/D receptor antagonist. Gen. Pharmac. 29:1997;293-303.
42. Pazos A., Probst A., Palacios J.M. Serotonin receptors in the human brain - III. Autoradiographic mapping of serotonin-1 receptors. Neuroscience. 21:1987;97-122.
43. 2-adrenergic receptor subtype mRNAs in human tissues. Molec. Brain Res. 16:1992;57-63.
44. Pilapil C., Welner S., Magnan J., Gauthier S., Quirion R. Autoradiographic distribution of multiple classes of opioid receptor binding sites in human forebrain. Brain Res. Bull. 19:1987;611-615.
45. Raynor K., Kong H., Mestek A., Bye L.S., Tian M., Liu J., Yu L., Reisine T. Characterization of the cloned human mu opioid receptor. J. Pharmac. exp. Ther. 272:1995;423-428.
46. Rodríguez-Puertas R., González-Maeso J., Meana J.J., Pazos A. Visualization of receptor-activated G proteins in postmortem human brain. Soc. Neurosci. Abstr. 24:1998;603.
47. 4 muscarinic receptor subtypes in Alzheimer's disease. Synapse. 26:1997;341-350.
48. 35S]guanylyl-5′-O-(thio)-triphosphate binding in the basal ganglia of aged rats. Neuroscience. 84:1998;1075-1083.
49. Selley D.E., Bidlack J.M. Effects of beta-endorphin on Mu and Delta opioid receptor-coupled G protein activity: low-Km GTPase studies. J. Pharmac. exp. Ther. 263:1992;99-104.
50. Selley D.E., Breivogel C.S., Childers S.R. Modification of opioid receptor-G-protein function by low pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G-proteins. Molec. Pharmac. 44:1993;731-741.
51. Selley D.E., Sim L.J., Xiao R., Liu Q., Childers S.R. μ-Opioid receptor-stimulated guanosine-5′-O-(γ-thio)-triphosphate binding in rat thalamus and cultured cell lines: signal transduction mechanisms underlying agonist efficacy. Molec. Pharmac. 51:1997;87-96.
52. 35S]thio]-triphosphate binding. Proc. natn. Acad. Sci. U.S.A. 92:1995;7242-7246.
53. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;8057-8066.
54. Sim L.J., Selley D.E., Xiao R., Childers S.R. Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmac. 307:1996;97-105.
55. 35S]GTPγS autoradiography in rat brain. J. Neurosci. 16:1996;2684-2692.
56. 35S]GTPγS binding. In Methods in Molecular Biology. Receptor Signal Transduction Protocols (ed. Challis R. A. J.), Vol. 83, pp. 117-132. Humana, Totowa.
57. 1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology. 27:1988;707-715.
58. o with μ-opioid receptors in guinea pig striatal membranes pretreated with micromolar concentrations of N-ethylmaleimide. J. Neurochem. 54:1990;841-848.
59. 4 receptors in the rat brain: evidence from combined in situ hybridization and receptor autoradiography. Synapse. 11:1992;171-183.
60. Vilaró M. T., Mengod G. and Palacios J. M. (1993) Advances and limitations of the molecular neuroanatomy of cholinergic receptors: the example of multiple muscarinic receptors. In Progress in Brain Research (ed. Cuello A. C.), Vol. 98, pp. 95-101. Elsevier, Amsterdam.
61. Voorn P., Brady L.S., Berendse H.W., Richfield E.K. Densitometrical analysis of opioid receptor ligand binding in the human striatum - I. Distribution of mu opioid receptor defines shell and core of the ventral striatum. Neuroscience. 75:1996;777-792.
62. 35S]guanosine-5′-O-(3-thio)triphosphate binding to rodent brain sections as visualized by in vitro autoradiography. Molec. Pharmac. 52:1997;623-631.
63. Wang H.-Y., Friedman E. Receptor-mediated activation of G proteins is reduced in postmortem brains from Alzheimer's disease patients. Neurosci. Lett. 173:1994;37-39.
64. Westlake T.M., Howlet A.C., Bonner T.I., Matsuda L.A., Herkenham M. Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience. 63:1994;637-652.
65. iα) in human brain: correlation with adenylyl cyclase activity. Neurochem. Int. 22:1993;285-291.
66. Zeng D.W., Lynch K.R. Distribution of alpha 2-adrenergic receptor mRNAs in the rat CNS. Molec. Brain Res. 10:1991;219-225.